Anavex Life Sciences Corp (AVXL)

[Investor2014]

The Australians funded the n=32 trial. They also requested an additional 104 weeks extension trial on behalf of the patients and care givers.

Would it not be reasonable, assuming results still appear promising, that they would find the money for a 300 patients trial that could just result in improved care and commensurate future savings, not to mention the ethical bonuses?

I think so despite your research findings.